Transfusion

publication venue for

Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease. 2021
Flat line in the blood bank: code H (hyperfibrinolysis)? 2020
A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients. 2020
Visual evidence of a hemolytic transfusion reaction identified by blood bank testing after emergency blood transfusion. 2019
Hereditary elliptocytosis of donor red blood cell unit detected during Coombs crossmatch. 2019
The power of a trained eye: fatal transfusion-transmitted anaplasmosis and a case study in investigative work. 2019
Heparin-induced thrombocytopenia suggested by microscopic examination of a below-knee amputation. 2018
Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah's Witness with hemorrhagic shock. 2018
Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. 2015
Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease. 2012
Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization. 2007
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. 2003
Does a patient with hereditary spherocytosis qualify for preoperative autologous blood donation? 1997
Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants. 2023
Visualization dashboard for blood product inventory management.. 63. 2023
Blood utilization in liver transplantation (BUILT): A multidisciplinary survey of transfusion practices.. 63. 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.. 62. 2022
Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality.. 62. 2022
Hemostatic efficacy of pathogen-reduced platelets in children undergoing cardiopulmonary bypass.. 62. 2021
Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).. 61. 2021
Transfusion practices in a large cohort of hospitalized children.. 61. 2021
A simplified CD34+ based preharvest prediction tool for HPC(A) collection.. 61. 2021
Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services.. 61. 2021
Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve.. 61. 2020
Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children.. 60. 2020
Rethinking the need for a platelet transfusion threshold of 50 × 10⁹ /L for lumbar puncture in cancer patients.. 60. 2020
Thawed solvent/detergent-treated plasma demonstrates comparable clinical efficacy to thawed plasma.. 60. 2020
Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States.. 60. 2020
Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?. 60 Suppl 3. 2020
Additive effects of blood donor smoking and gamma irradiation on outcome measures of red blood cell transfusion.. 60. 2020
Increase in Google search interest for paid plasma donation in the United States during and after the great recession.. 59. 2019
Pathogen reduced plasma products: a clinical practice scientific review from the AABB.. 59. 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee.. 59. 2019
Red blood cells donated by smokers: A pilot investigation of recipient transfusion outcomes.. 59. 2019
Influence of blood storage age on immune and coagulation parameters in critically ill transfused patients.. 59. 2019
Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery.. 59. 2019
Evaluation of peripheral blood mononuclear cell collection by leukapheresis.. 59. 2019
Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.. 59. 2019
The impact of Daratumumab on transfusion service costs.. 59. 2019
Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States.. 59. 2018
Platelet transfusion practices in immune thrombocytopenia related hospitalizations.. 59. 2018
Logistical and safety implications of temperature-based acceptance of returned red blood cell units.. 58. 2018
Assessing our current practice: point prevalence studies in transfusion medicine.. 58. 2018
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.. 58. 2017
Influence of cryoprecipitate, Factor XIII, and fibrinogen concentrate on hyperfibrinolysis.. 57. 2017
Intrauterine transfusions for severe fetal anemia and hydrops due to de novo εγδβ-thalassemia.. 57. 2017
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.. 56. 2016
Cryoprecipitate indications and patterns of use in the pediatric intensive care unit: inappropriate transfusions and lack of standardization.. 56. 2016
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.. 56. 2015
A novel bioreactor and culture method drives high yields of platelets from stem cells.. 56. 2015
Can the interval between antibody identifications be increased for alloimmunized patients?. 56. 2015
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.. 56. 2015
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.. 55. 2015
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.. 55. 2015
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.. 55. 2015
A comparison of adverse reaction rates for PAS C versus plasma platelet units.. 54. 2014
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.. 54. 2013
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).. 54. 2013
Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.. 54. 2013
Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications.. 53. 2012
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.. 53. 2012
Cardiovascular disease risk assessment and prevention in blood donors.. 52. 2012
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.. 52. 2011
Demographic differences in estimated blood donor eligibility prevalence in the United States.. 52. 2011
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation.. 51. 2011
Transfusion medicine illustrated. The role of plasmapheresis in the multimodal treatment of anti-Pr cold agglutinin disease.. 50. 2010
Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.. 50. 2009
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.. 48. 2008
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.. 46. 2006
Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.. 46. 2006
Removal of ABO-incompatible red cells from lymphocytapheresis and granulocytapheresis components before transfusion.. 37. 1997
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients.. 31. 1991
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura.. 28. 1988
Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation?. 23. 1983
A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.. 22. 1982
Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.. 17. 1977
Glanzmann's thrombasthenia; assessment of the response to platelet transfusions.. 15. 1975
Blood group studies of jungle Indians of the Mato Grosso.. 2. 1962
Response to Wirtz et al: The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients. 2021
Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic. 2020
Historical ABO blood group discrepancy: a blessing in disguise to unravel a medical identity theft. 2017
Babesia screening: the importance of reporting and calibration in cost-effectiveness models. 2016
Universal WBC reduction and patient advocacy. 2000
Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin. 1986
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. 2012
Conservation of O- red blood cells: a fresh look at a shared responsibility.. 58. 2018
What do we know about intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia?. 56. 2016
Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss.. 52. 2012
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?. 51. 2011
Identifying babies with neonatal alloimmune thrombocytopenia and the responsible antigens.. 47. 2007
Vitamin K antagonist reversal strategies: Systematic review and network meta-analysis from the AABB. 2022
Transfusion management for children supported by extracorporeal membrane oxygenation. 2021
Assessment of platelet function utilizing viscoelastic testing. 2020
The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing. 2020
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design. 2020
The use of coagulation factor concentrates for perioperative bleeding management - a global perspective. 2020
Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura. 2019
Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials? 2019
Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. 2018
How do I perform hematopoietic progenitor cell selection? 2016
Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines. 2014
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME). 2011
2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? 2011
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. 2006

VIVO Weill Cornell Medical College

Transfusion Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)